| Blunting neuroinflammation with resolvin D1 prevents early pathology in a rat model of Parkinson’s disease P Krashia, A Cordella, A Nobili, L La Barbera, M Federici, A Leuti, ... Nature communications 10 (1), 3945, 2019 | 159 | 2019 |
| Dietary Vitamin E as a protective factor for Parkinson's disease: clinical and experimental evidence T Schirinzi, G Martella, P Imbriani, G Di Lazzaro, D Franco, VL Colona, ... Frontiers in Neurology 10, 148, 2019 | 105 | 2019 |
| GBA‐Related Parkinson's Disease: Dissection of Genotype–Phenotype Correlates in a Large Italian Cohort S Petrucci, M Ginevrino, I Trezzi, E Monfrini, L Ricciardi, A Albanese, ... Movement Disorders 35 (11), 2106-2111, 2020 | 95 | 2020 |
| Self-reported needs of patients with Parkinson’s disease during COVID-19 emergency in Italy T Schirinzi, R Cerroni, G Di Lazzaro, C Liguori, S Scalise, R Bovenzi, ... Neurological Sciences 41, 1373-1375, 2020 | 88 | 2020 |
| Alpha-synuclein in Parkinson’s disease and other synucleinopathies: From overt neurodegeneration back to early synaptic dysfunction P Calabresi, A Mechelli, G Natale, L Volpicelli-Daley, G Di Lazzaro, ... Cell death & disease 14 (3), 176, 2023 | 87 | 2023 |
| Systemic activation of Nrf2 pathway in Parkinson's disease S Petrillo, T Schirinzi, G Di Lazzaro, J D'Amico, VL Colona, E Bertini, ... Movement Disorders 35 (1), 180-184, 2020 | 78 | 2020 |
| Physical activity changes and correlate effects in patients with Parkinson's disease during COVID‐19 lockdown T Schirinzi, G Di Lazzaro, C Salimei, R Cerroni, C Liguori, S Scalise, ... Movement disorders clinical practice 7 (7), 797-802, 2020 | 65 | 2020 |
| Amyloid-mediated cholinergic dysfunction in motor impairment related to Alzheimer’s disease T Schirinzi, F Di Lorenzo, GM Sancesario, G Di Lazzaro, V Ponzo, ... Journal of Alzheimer's Disease 64 (2), 525-532, 2018 | 57 | 2018 |
| Young-onset and late-onset Parkinson's disease exhibit a different profile of fluid biomarkers and clinical features T Schirinzi, G Di Lazzaro, GM Sancesario, S Summa, S Petrucci, ... Neurobiology of Aging 90, 119-124, 2020 | 51 | 2020 |
| Assessment of motor impairments in early untreated Parkinson's disease patients: the wearable electronics impact M Ricci, G Di Lazzaro, A Pisani, NB Mercuri, F Giannini, G Saggio IEEE journal of biomedical and health informatics 24 (1), 120-130, 2019 | 51 | 2019 |
| Effectiveness of robot-assisted gait training on motor impairments in people with Parkinson’s disease: a systematic review and meta-analysis M Alwardat, M Etoom, S Al Dajah, T Schirinzi, G Di Lazzaro, PS Salimei, ... International Journal of Rehabilitation Research 41 (4), 287-296, 2018 | 47 | 2018 |
| Voice in Parkinson's disease: a machine learning study A Suppa, G Costantini, F Asci, P Di Leo, MS Al-Wardat, G Di Lazzaro, ... Frontiers in neurology 13, 831428, 2022 | 44 | 2022 |
| CSF α-synuclein inversely correlates with non-motor symptoms in a cohort of PD patients T Schirinzi, GM Sancesario, G Di Lazzaro, B Biticchi, VL Colona, ... Parkinsonism & Related Disorders 61, 203-206, 2019 | 41 | 2019 |
| Cerebrospinal fluid biomarkers profile of idiopathic normal pressure hydrocephalus T Schirinzi, GM Sancesario, G Di Lazzaro, A D’Elia, P Imbriani, S Scalise, ... Journal of Neural Transmission 125, 673-679, 2018 | 41 | 2018 |
| Dissecting the Phenotype and Genotype of PLA2G6‐Related Parkinsonism F Magrinelli, S Mehta, G Di Lazzaro, A Latorre, MJ Edwards, B Balint, ... Movement Disorders 37 (1), 148-161, 2022 | 37 | 2022 |
| Technology-based objective measures detect subclinical axial signs in untreated, de novo Parkinson’s disease G Di Lazzaro, M Ricci, M Al-Wardat, T Schirinzi, S Scalise, F Giannini, ... Journal of Parkinson's disease 10 (1), 113-122, 2020 | 32 | 2020 |
| Levels of amyloid-beta-42 and CSF pressure are directly related in patients with Alzheimer’s disease T Schirinzi, G Di Lazzaro, GM Sancesario, VL Colona, E Scaricamazza, ... Journal of Neural Transmission 124, 1621-1625, 2017 | 32 | 2017 |
| Association between physical activity and dementia’s risk factors in patients with Parkinson’s disease M Alwardat, T Schirinzi, G Di Lazzaro, GM Sancesario, D Franco, ... Journal of Neural Transmission 126, 319-325, 2019 | 30 | 2019 |
| Assessment of serum uric acid as risk factor for tauopathies T Schirinzi, G Di Lazzaro, VL Colona, P Imbriani, M Alwardat, ... Journal of Neural Transmission 124, 1105-1108, 2017 | 29 | 2017 |
| Expanding the Spectrum of Movement Disorders Associated With C9orf72 Hexanucleotide Expansions C Estevez-Fraga, F Magrinelli, D Hensman Moss, E Mulroy, G Di Lazzaro, ... Neurology: Genetics 7 (2), e575, 2021 | 27 | 2021 |
